For the first time ever, gene therapy is being used to treat an "ultra-rare disease" in a young Toronto boy.
Michael Pirovolaki has hereditary spastic paraplegia type 50, otherwise known as SPG50 — a neurodegenerative disease so rare, it's believed Michael may be the only child in Canada afflicted by the condition.
As Caryn Lieberman reports, his family raised more than $3 million to pay for the research and development of a treatment to help save their son.
For more info, please go to https://globalnews.ca/news/9060326/spastic-paraphlegia-ultra-rare-disease-gene-therapy/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #SPG50 #Health
Michael Pirovolaki has hereditary spastic paraplegia type 50, otherwise known as SPG50 — a neurodegenerative disease so rare, it's believed Michael may be the only child in Canada afflicted by the condition.
As Caryn Lieberman reports, his family raised more than $3 million to pay for the research and development of a treatment to help save their son.
For more info, please go to https://globalnews.ca/news/9060326/spastic-paraphlegia-ultra-rare-disease-gene-therapy/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#GlobalNews #SPG50 #Health
- Category
- U.S. & Canada
- Tags
- global news, Canada, gene therapy
Sign in or sign up to post comments.
Be the first to comment